Clinical trial
Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery
NCT00845364 is registered in ClinicalTrials.gov with University Hospital Birmingham as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolic Support With Perhexiline to Protect Myocardium Undergoing Coronary Artery Surgery
- Lead sponsor
- University Hospital Birmingham
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- April 30, 2010
- Enrollment
- 290 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.